ClinicalTrials.gg
Status unknownNCT02901808IRRE NOMIUpdated Oct 4, 2017

Registeranalysis for the Examination of NOMI

An observational study in Mesenteric Ischemia, sponsored by Universität des Saarlandes. Status unknown at 1 site in Germany. Open to participants aged Up to 100 Years. Per ClinicalTrials.gov, last updated 2017-10-04.

Sponsored by Universität des Saarlandes · Observational

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
10,000
Ages
Up to 100 Years
Sex
All
01

Study summary

The registry includes patients undergoing cardiovascular and thoracic surgery at the Saarland University Medical Center, Homburg/Saar, Germany. This study is a monocentric, retrospective study investigating the development of NOMI and outcome of patients.

Read the detailed description

All data were acquired from the hospital electronic health record and the picture archiving computer system (PACS).

NOMI was suspected if the following clinical signs occured:

new onset of oliguria (urine output \<0.5 mL/kg/hour for at least 6 hours) or anuria, abdominal distention with decreased or absent bowel sounds, elevated serum lactate levels >5.0mmol/L or metabolic acidosis (base excess \<-5mmol/L).

In accordance to the definition of cardiogenic shock angiography was performed in patients with a systolic blood pressure >90 mmHg and a cardiac index >1.8 L/minute/m².

02

Conditions studied

  • Mesenteric Ischemia

Browse trials for

Keywords

  • NOMI
  • Angiography
  • Digital Subtraction Angiography (DSA)
03

In context

Mesenteric Ischemia

40 studies on the registry are indexed under Mesenteric Ischemia; 14 are open to participants now.

This study's enrollment of 10,000 is above the median of 154 across 26 observational studies indexed under Mesenteric Ischemia.

Browse Mesenteric Ischemia studies →

Lead sponsor

Universität des Saarlandes is the lead sponsor of 68 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Cardio-thoracic surgical patients

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The investigators include anonymous data from patients with cardio-thoracic surgery

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
10,000 participants (actual)
Patient registry
No

Groups and cohorts

  • NOMI

    Patients suffering from NOMI

  • No-NOMI

    Patients not suffering from NOMI

06

What researchers measure

Primary outcomes

  1. Development of NOMI

    Clinical signs of NOMI

    Time frame: at the day of surgery, day zero

Secondary outcomes

  1. Length of stay

    Length of stay will be measured upon the time spent on intensive care unit and in the hospital

    Time frame: at the day of surgery, day zero up to 365 days

  2. Mechanical ventilation

    Length of mechanical ventilation will be measured upon the time spent on intensive care unit

    Time frame: at the day of surgery, day zero up to 365 days

  3. Mortality

    Mortality will be measured upon patients leaving the hospital dead or alive.

    Time frame: at the day of surgery, day zero up to 365 days

07

Study locations

1 site
  • Saarland University Medical Center
    Homburg, Saarland 66421, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2008, a primary completion of Dec 2014 and a completion of Dec 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2016
First posted
Sep 15, 2016
Start
Jan 2008
Primary completionActual
Dec 2014
CompletionEst.
Dec 2017
Last update
Oct 4, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 4, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02901808
Lead sponsor
Universität des Saarlandes
Responsible party
Peter Minko (Assistant Medical Director, Universität des Saarlandes) — Principal investigator
First posted
Sep 15, 2016
Start date
Jan 2008
Primary completion
Dec 2014
Completion
Dec 2017 (estimated)
Last update
Oct 4, 2017

Study contacts

Arno Buecker, MD
study director · Department of Diagnostic and Interventional Radiology
Hans-Joachim Schäfers, MD
study director · Department of Thoracic and Cardiovascular Surgery

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion